back to overview

news

MTIP Healthcare Clinic 2019

April 18, 2019 + Jessica Di Palo
5 Min read

Basel, April 9th, 2019 MTIP presented its journey in the healthtech sector with its insights on the current industry developments, its great portfolio and an exciting outlook of the future with MTIP Fund ll.

The MTIP Healthcare Clinic 2019 took place in the Victoria Hotel Basel. The guests were welcomed by MTIP’s chairman Dr. Felix Grisard and in the following overview, Dr. Christoph Kausch enlightened the invited audience about MTIP’s main differentiators. MTIP is one of the leading European investors in Healthtech and connects the traditional healthcare sector with new technologies, emerging from the IT sector. By being one of the least digitalized sectors and decreasing productivity over the last couple of years, healthcare strives for improvements. Digitalization in healthcare is just emerging and offers enormous opportunities which are mainly uncorrelated to the traditional financial markets and therefore offer a highly attractive risk-reward profile for investors.

Based on this, Dr. Claudia Colciago presented MTIP’s view on future developments in the healthcare sector and emphasized the importance of investing in companies with a strong and sustainable growth trajectory. Artificial intelligence will have a major impact on healthcare, but AI technology can only be leveraged if a robust framework to collect, structure, and share data is established beforehand. In the future, Digital Health companies will help in delivering affordable and efficient care to patients all around the globe.

Speaking about excellent examples of affordable and efficient care, MTIP’s portfolio was presented by the investment partner David Germonpré. Last year’s new investments Quanta Dialysis, Lumeon and Cynerio were presented by their respective management team. Thanks to their expertise, the audience had a deep dive into several hot topics around chronic diseases, decentralized care, optimization of treatment delivery and cybersecurity.

MTIP was able to establish this great portfolio in under three years and more is coming. The future steps and the key terms of the MTIP Fund II concluded the presentations. The audience was fascinated by MTIP’s development and engaged in insightful discussion during the Apéro riche, enjoying a stunning view over Basel.

Share the Article

news

Digital healthcare: patient-first?

Digital Healthcare Report 2021 in collaboration with Dealroom and INKEF Capital

blog

SFDR – How does MTIP approach the EU’s Sustainable Disclosure Regulation?

New SFDR obligations

news

MTIP Announces Strong First Closing of Fund II to drive Healthtech Innovation

First Closing of Fund II

blog

How to pitch to a healthtech Investor

Blog Pitching

news

MTIP invests in Koa Health to make mental health treatment more accessible

New investment in Koa Health

news

MTIP scored fantastic grades in the UNPRI assessment report of 2020

UNPRI Report grades 2020

press

4 Health VCs Share Their Business Priorities and What is Next

Interview Techtour

news

MTIP invests in Trialbee

New investment in Trialbee

news

TytoCare closes $50 million round as the demand for telehealth accelerates

TytoCare closes new round

news

The digital healthtech sector is expanding – and so are we!

Two new empolyees start in April

news

MTIP has sucessfully exited Blueprint Genetics

Blueprint exit January 2020

news

New MTIP investment in Oviva

New investment in Oviva

press

Whitepaper: A positive prognosis for the future of healthtech

Our first Whitepaper

press

Elite Summit 2019 – Interview with our Managing Partner Christoph Kausch

Elite Summit 2019

news

MTIP Healthcare Clinic 2019

Healthcare clinic 2019

New MTIP investment in Cynerio

New investment in Cynerio

news

MTIP invests in Lumeon Ltd.

New investment in Lumeon

Magenverkleinerung mit der Handnähmaschine

Nitinotes news paper article

news

New MTIP investment in Quanta Dialysis Technologies

New investment in Quanta

news

MTIP’s Healthcare Clinic 2018

Healthcare Clinic 2018

press

Interview with Christoph Kausch in biotechandmoney

interview Bioandtechnology

news

New MTIP investment – Nitinotes Series A Round

New investment in Nitinotes

news

New investment in an Israeli based digital health company TytoCare

New investment in TytoCare

news

MTIP joins United Nations-supported Principles for Responsible Investments

MTIP signs Principles for Responsible Investments

news

MTIP invests in Blueprint Genetics

new investment in Blueprint Genetics